Abstract
The G184C and G134A single nucleotide polymorphisms (SNPs) of the CYP1A1 gene result in Ala62Pro and Gly45Asp substitutions, respectively. Here, we tested whether these SNPs are associated with an alteration in lung cancer incidence. We examined 80 Korean subjects with lung cancer and 240 age- and sex-matched controls. For each subject, the CYP1A1 gene was PCR amplified and sequenced. We observed that the odds ratio (OR) for lung cancer was 3.37 higher in subjects with the G184C polymorphism than in controls (95% confidence interval (CI), 0.89~12.73, P = 0.07). In contrast, the OR for lung cancer was 1.23 in subjects with the G134A polymorphism compared to controls (95% CI, 0.68~2.20, P = 0.49). The G184C polymorphism exacerbated the effects of smoking on lung cancer development. Gene-smoking interaction analyses revealed that past or present smokers with the G184C polymorphism had a higher incidence of lung cancer (OR, 24.72; 95% CI, 4.48~136.31; P < 0.01) than control smokers (OR, 6.65; 95% CI, 2.72~16.28; P < 0.01). However, there was only a slight difference in the ORs for lung cancer between control smokers and smokers with the G134A polymorphism. These findings suggest that the G184C polymorphism, but not the G134A polymorphism, is associated with an increased risk of lung cancer.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- CYP:
-
cytochrome P-450
- CI:
-
confidence interval
- OR:
-
odds ratio
- PCR:
-
polymerase chain reaction
- SNP:
-
single nucleotide polymorphism
- WT:
-
wild-type
References
Bartsch, H., Nair, U., Risch, A., Rojas, M., Wikman, H. and Alexandrov, K. (2000). Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol. Biomarkers Prev., 9, 3–28.
Crofts, F., Cosma, G.N., Currie, D., Taioli, E., Toniolo, P. and Garte, S.J. (1993). A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis., 14, 1729–1731.
Cascorbi, I., Brockmoller, J. and Roots, I.A. (1996). C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res., 56, 4965–4969.
Chevalier, D., Allorge, D., Lo-Guidice, J.M., Cauffiez, C., Lhermitte, M., Lafitte, J.J. and Broly, F. (2001). Detection of known and two novel (M331I and R464S) missense mutations in the human CYP1A1 gene in a French Caucasian population. Hum. Mutat., 17, 355.
Hayashi, S., Watanabe, J., Nakachi, K. and Kawajiri, K. (1991). Genetic linkage of lung cancer-associated Mspl polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J. Biochem., 110, 407–411.
Hung, R.J., Boffetta, P., Brockmoller, J., Butkiewicz, D., Cascorbi, I., Clapper, M.L., Garte, S., Haugen, A., Hirvonen, A., Anttila, S., Kalina, I., Le Marchand, L., London, S.J., Rannug, A., Romkes, M., Salagovic, J., Schoket, B., Gaspari, L. and Taioli, E. (2003). CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis, 24, 875–882.
McManus, M.E., Burgess, W.M., Veronese, M.E., Huggett, A., Quattrochi, L.C. and Tukey, R.H. (1990). Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res., 50, 3367–3376.
Park, D.W., Jin, B., Jang, D., Yang, K., Park, J.D., Lee, Y.S. and Ryu, D.Y. (2004). Genetic polymorphisms of CYP1A1 in a Korean population. Arch. Toxicol., 78, 306–308.
Spurr, N.K., Gough, A.C., Stevenson, K. and Wolf, C.R. (1987). Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res., 15, 5901.
Smart, J. and Daly, A.K. (2000). Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics, 10, 11–24.
Saito, S., Iida, A., Sekine, A., Ogawa, C., Kawauchi, S., Higuchi, S., Ohno, M. and Nakamura, Y. (2002). 906 variations among 27 genes encoding cytochrome P450 (CYP) enzymes and aldehyde dehydrogenases (ALDHs) in the Japanese population. J. Hum. Genet., 47, 419–444.
Solus, J.F., Arietta, B.J., Harris, J.R., Sexton, D.P., Steward, J.Q., McMunn, C., Ihrie, P., Mehall, J.M., Edwards, T.L. and Dawson, E.P. (2004). Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics, 5, 895–931.
Song, N., Tan, W., Xing, D. and Lin, D. (2001). CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis, 22, 11–16.
Sugimura, H., Wakai, K., Genka, K., Nagura, K., Igarashi, H., Nagayama, K., Ohkawa, A., Baba, S., Morris, B.J., Tsugane, S., Ohno, Y., Gao, C., Li, Z., Takezaki, T., Tajima, K. and Iwamasa, T. (1998). Association of lle462Val (Exon 7) polymorphism of cytochrome P450 IA1 with lung cancer in the Asian population: further evidence from a case-control study in Okinawa. Cancer Epidemiol. Biomarkers Prev., 7, 413–417.
Vineis, P., Veglia, F., Benhamou, S., Butkiewicz, D., Cascorbi, I., Clapper, M.L., Dolzan, V., Haugen, A., Hirvonen, A., Ingelman-Sundberg, M., Kihara, M., Kiyohara, C., Kremers, P., LeMarchand, L., Ohshima, S., Pastorelli, R., Rannug, A., Romkes, M., Schoket, B., Shields, P., Strange, R.C., Stucker, I., Sugimura, H., Garte, S., Gaspari, L. and Taioli, E. (2003). CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int. J. Cancer, 104, 650–657.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ryu, DY., Huang, M., Park, C. et al. Association of the G134A and G184C Polymorphisms in the CYP1A1 Gene with Lung Cancer Incidence. Toxicol Res. 24, 109–112 (2008). https://doi.org/10.5487/TR.2008.24.2.109
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2008.24.2.109